Showing results (2421-2430 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|August 23, 2023
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experienceTomáš Kabut, Barbora Weinbergerová, František Folber, et al.Bone Marrow Transplantation|September 2, 2023
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMTArnon Nagler, Myriam Labopin, Nicolaus Kröger, et al.Bone Marrow Transplantation|March 15, 2026
Relapse patterns focusing on central nervous system involvement after allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemiaJong Hyuk Lee, Jaehyun Ahn, Daehun Kwag, et al.Bone Marrow Transplantation|March 28, 2026
Risk factors for alloimmune lung syndromes after allogeneic hematopoietic cell transplantation in childrenLinde Dekker, Birgitta A Versluys, Coco C H de Koning, et al.Bone Marrow Transplantation|April 1, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committeeChristopher Armstrong, Kavita Raj, Giorgia Battipaglia, et al.Bone Marrow Transplantation|April 9, 2026
Umbilical cord blood transplantation in children with Diamond-Blackfan anemiaFernanda Volt, Malika Akhoudas, Chantal Kenzey, et al.Bone Marrow Transplantation|April 28, 2026
Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell diseaseReem Alasbali, Mohsen Alzahrani, Karina Wilkerson, et al.Bone Marrow Transplantation|April 8, 2026
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignanciesAndrea Gantner, Svenja Labuhn, Daniel Fürst, et al.Bone Marrow Transplantation|May 8, 2026
Allogeneic hematopoietic stem cell transplantation in elderly patients with AML and MDS: navigating risks and optimizing outcomesMingyang Wang, Jieya Luo, Didier Blaise, et al.Bone Marrow Transplantation|April 16, 2026
Outcomes of allogeneic transplantation in blast-phase myeloproliferative neoplasms: one-third achieve long-term survivalKordelia Barbullushi, Nico Gagelmann, Kristin Rathje, et al.Pageof 993